While Western pharmaceutical corporations are still working on the coronavirus drug, the European Union does not rule out the possibility of buying the vaccine Sputnik V developed by Russian scientists.
Race for the vaccine was another failed test of Western solidarity. On both sides of the Atlantic, governments are placing multi-million dollar orders for a drug that pharmaceutical corporations have not yet created.
The expert community has repeatedly warned that vaccination is not only necessary in countries that can afford it. Otherwise, the coronavirus will terrorize humanity time and again. Ignoring these recommendations, both Europe and the United States have already launched a real confrontation, creating a dangerous deficit on the market.
The problem is complicated by the fact that the virus does not wait for pharmaceutical giants to find a lifesaving drug. Coronavirus is spreading rapidly in Europe, threatening it with a new wave of pandemic, severe quarantine and another blow to the economy.
The French capital has already introduced a mandatory and ubiquitous mask regime. German authorities want to ban all major events, concerts and festivals at least until December 31 because of the spread of COVID-19. Spain intends to attract an army to fight the coronavirus. Hundreds of COVID-19 foci have been recorded all over Europe. Against this background, Greek MP Nicolas Gonzales Casares proposes to ask for help from Russia.
He has already sent a corresponding request to the European Commission. In his appeal, the politician asked how the EC treated the newly registered Russian vaccine and whether it was considering buying the drug.
The Russian coronavirus vaccine was the first registered vaccine of its kind. So far, there have been attempts in the West to criticize Russian scientists’ development, accusing them of rushing. The reasons for such statements were political and were due to the fact that Western countries did not have their own vaccine. Meanwhile, many states, including Saudi Arabia, the United Arab Emirates, Mexico and others, were already interested in the Russian drug.